| 摘要 |
This invention provides solid oral dosage forms for treating gastric disorders, comprising effective doses of (a) famotidine or pharmaceutically acceptable salt thereof, and (b) alginic acid, wherein the famotidine, or pharmaceutically acceptable salt thereof, and alginic acid are physically separated by a pharmaceutically acceptable barrier which is impermeable to alginic acid. This invention also provides methods for manufacturing the instant solid oral dosage form, and therapeutic and prophylactic methods using same. |
